| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.AUTREV.2004.10.003 |
| P698 | PubMed publication ID | 15990071 |
| P2093 | author name string | Richard D Sontheimer | |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | subacute cutaneous lupus erythematosus | Q7630706 |
| P304 | page(s) | 253-263 | |
| P577 | publication date | 2004-11-12 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings | |
| P478 | volume | 4 |
| Q43260832 | A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus |
| Q40546253 | A girl with cutaneous lesions, polyarthritis, and antinuclear antibodies positivity |
| Q37805550 | A systematic review of drug-induced subacute cutaneous lupus erythematosus |
| Q58899727 | Acute pancreatitis as initial manifestation of systemic lupus erythematosus and subacute cutaneous lupus erythematosus: report of two cases |
| Q37140639 | An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". |
| Q38170245 | Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases. |
| Q54041325 | Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study. |
| Q36035808 | Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy |
| Q45052982 | Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility. |
| Q89169605 | Case of severe acute lupus myocarditis and multiple-organ failure |
| Q53746240 | Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. |
| Q37754648 | Clinical implication of autoantibodies in patients with systemic rheumatic diseases |
| Q39587357 | Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus |
| Q37608166 | Cutaneous lupus erythematosus: An update |
| Q38086856 | Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis. |
| Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
| Q94418532 | Effectiveness of Quinacrine (Mepacrine) in Photosensitive Autoimmune Diseases, Lupus Erythematosus, and Dermatomyositis: Report on 38 Cases and Literature Review |
| Q37953846 | Environment and lupus-related diseases |
| Q51541832 | Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI. |
| Q36793158 | Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. |
| Q83277663 | Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative |
| Q90331291 | James Neil Gilliam, MD-the career arc of a patient-oriented translational clinical investigation changemaker in rheumatologic skin disease |
| Q62073560 | Kutaner Lupus erythematodes |
| Q58133847 | Lansoprazole-Induced Subacute Cutaneous Lupus Erythematosus |
| Q41942268 | Light induced subacute cutaneous lupus erythematodes: diagnosis and management |
| Q38659241 | Lupus erythematosus revisited. |
| Q37609869 | Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects |
| Q94674280 | New Criteria for Lupus |
| Q37778645 | Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates |
| Q37778642 | Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets. |
| Q37038484 | Pathophysiology of cutaneous lupus erythematosus |
| Q36853343 | Photoprotective habits of patients with cutaneous lupus erythematosus |
| Q64137979 | Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry |
| Q35215275 | Rowell's Syndrome to ds-DNA Negative Lupus Nephritis: A Yet Unreported Progression |
| Q38851071 | Smoking and obesity in systemic lupus erythematosus: a cross-sectional study |
| Q37151317 | Subacute cutaneous lupus erythematosus triggered by radiotherapy. |
| Q37778654 | The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus |
| Q38220705 | The lip in lupus erythematosus |
| Q33692688 | The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus |
| Q37001577 | The use of topical calcineurin inhibitors in lupus erythematosus: an overview. |
| Q37044632 | Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation |
| Q84697085 | Treatment of cutaneous lupus erythematosus |
| Q41938203 | Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. |
| Q36932377 | Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). |
| Q84434376 | [Does cutaneous lupus erythematodes really exist?] |
| Q83869346 | [Skin manifestations in lupus erythematosus: clinical aspects and therapy] |
Search more.